Arrowstreet Capital, Limited Partnership Harvard Bioscience Inc Transaction History

Arrowstreet Capital, Limited Partnership

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$3.28 - $6.42 $252,671 - $494,558	-77,034 Closed	0 $0
Q1 2022 May 13, 2022	SELL	$5.16 - $7.14 $580,567 - $803,342	-112,513 Reduced 59.36%	77,034 $478,000
Q4 2021 Feb 14, 2022	SELL	$6.37 - $8.18 $178,818 - $229,628	-28,072 Reduced 12.9%	189,547 $1.34 Million
Q3 2021 Nov 12, 2021	SELL	$6.98 - $8.47 $815,403 - $989,465	-116,820 Reduced 34.93%	217,619 $1.52 Million
Q2 2021 Aug 13, 2021	BUY	$5.44 - $8.4 $758,711 - $1.17 Million	139,469 Added 71.53%	334,439 $2.79 Million
Q1 2021 May 14, 2021	SELL	$3.91 - $6.99 $17,204 - $30,756	-4,400 Reduced 2.21%	194,970 $1.07 Million
Q3 2020 Nov 12, 2020	BUY	$2.75 - $4.2 $376,354 - $574,795	136,856 Added 218.92%	199,370 $600,000
Q2 2020 Aug 12, 2020	BUY	$2.12 - $3.14 $87,373 - $129,411	41,214 Added 193.49%	62,514 $194,000
Q3 2019 Nov 14, 2019	BUY	$1.59 - $3.47 $33,867 - $73,911	21,300 New	21,300 $65,000
Q2 2019 Aug 14, 2019	SELL	$1.93 - $4.59 $60,779 - $144,548	-31,492 Closed	0 $0
Q1 2019 May 15, 2019	SELL	$2.77 - $4.38 $22,190 - $35,088	-8,011 Reduced 20.28%	31,492 $136,000
Q3 2018 Nov 14, 2018	BUY	$5.0 - $6.65 $71,500 - $95,095	14,300 Added 56.74%	39,503 $207,000
Q1 2018 May 14, 2018	BUY	$3.3 - $5.15 $83,169 - $129,795	25,203 New	25,203 $126,000

30.6M

700

2.1K

Ticker HBIO
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 41,636,500
Market Cap $89.1M
Description
Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products, and services that enables fundamental research, discovery, and pre-clinical testing for drug development in the United States and internationally. The company offers cellular and molecular technology instruments, such as syringe and peristaltic pump products, as w...

Get notified when there are updates to the investment portfolio of Arrowstreet Capital, Limited Partnership, based on Form 13F filings with the SEC.

Stay updated on Arrowstreet Capital, Limited Partnership with notifications on news.